• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌二醇受体与人类乳腺癌及其转移灶的预后

Estradiol receptor and prognosis in human breast cancer and its metastases.

作者信息

Heise E, Görlich M

机构信息

WITEGA gGmbH, Berlin, FGR.

出版信息

Neoplasma. 1993;40(1):55-7.

PMID:8350949
Abstract

Follow-up of 86 patients for at least 40 months confirmed age dependency of receptor binding capacity in primary breast tumors but not in lymph node metastases. In most cases receptor binding capacity was higher in lymph node metastases than in primary tumors. Prognosis of the disease expressed as percentage of patients who survived and had a disease-free interval is related to receptor binding capacity of the primary tumors investigated. In our investigation, a value of 60 fmol/mg protein seems to be a suitable cut-off value to distinguish between breast cancer patients with good and bad prognosis. Receptor levels of lymph node metastases showed a similar behaviour as those of primary tumors related to percentage of patients who survived, but not to disease-free interval.

摘要

对86例患者进行至少40个月的随访,证实原发性乳腺肿瘤中受体结合能力与年龄有关,而在淋巴结转移灶中则不然。在大多数情况下,淋巴结转移灶中的受体结合能力高于原发性肿瘤。以存活且无病间期的患者百分比表示的疾病预后与所研究原发性肿瘤的受体结合能力有关。在我们的研究中,60 fmol/mg蛋白的值似乎是区分预后良好和不良的乳腺癌患者的合适临界值。淋巴结转移灶的受体水平与存活患者的百分比相关时,表现出与原发性肿瘤相似的行为,但与无病间期无关。

相似文献

1
Estradiol receptor and prognosis in human breast cancer and its metastases.雌二醇受体与人类乳腺癌及其转移灶的预后
Neoplasma. 1993;40(1):55-7.
2
Estradiol receptor and prognostic parameters of human breast cancer.雌激素受体与人类乳腺癌的预后参数
Neoplasma. 1999;46(2):112-6.
3
Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.雌激素受体阳性乳腺癌转移:淋巴管和淋巴结中激素敏感性及肿瘤侵袭性的改变
Cancer Res. 2006 Sep 15;66(18):9308-15. doi: 10.1158/0008-5472.CAN-06-1769.
4
Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.乳腺癌细胞学确诊腋窝淋巴结转移化疗后病理完全缓解后隐匿性腋窝淋巴结转移的预后意义
Cancer. 2009 Apr 15;115(8):1605-12. doi: 10.1002/cncr.24173.
5
Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status.基底型乳腺癌的疾病复发时间:肿瘤大小和淋巴结状态的影响。
Cancer. 2009 Nov 1;115(21):4917-23. doi: 10.1002/cncr.24573.
6
Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients.乳腺癌患者内乳淋巴结复发的诊断、治疗及预后
Breast Cancer Res Treat. 2005 Feb;89(3):271-5. doi: 10.1007/s10549-005-2469-y.
7
Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.腋窝淋巴结隐匿性转移作为长期随访的淋巴结阴性乳腺癌生存的预测指标
Breast J. 2004 May-Jun;10(3):174-80. doi: 10.1111/j.1075-122X.2004.21328.x.
8
Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.具有单一激素受体阳性表型的乳腺癌的生物学和临床特征
J Clin Oncol. 2007 Oct 20;25(30):4772-8. doi: 10.1200/JCO.2007.12.2747. Epub 2007 Sep 17.
9
The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.化疗对人乳腺导管癌原发肿瘤及淋巴结转移灶中雌激素受体状态的影响。
Oncol Rep. 2007 Feb;17(2):385-91.
10
Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.新辅助化疗的临床和病理反应与局部晚期乳腺癌预后的关系
J Surg Oncol. 2002 May;80(1):4-11. doi: 10.1002/jso.10090.